Ribonucleoside monophosphate biosynthetic process

pathway activity — cross-omics
GO:0009156Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Ribonucleoside monophosphate biosynthetic process pathway is significantly associated with the RNA expression of multiple genes, with the LUAD cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are GBP5, CXCL11, and ZNF683, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Ribonucleoside monophosphate biosynthetic process activity versus GBP5 in LUAD (Pearson r = 0.26).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUADGBP5 →+0.821+0.114<.001.00234
LUADCXCL11 →+1.240+0.117<.001.00634
LUADZNF683 →+0.490+0.105.002.00525
LUADCALHM6 →+0.774+0.146.001.00334
LUADTBX21 →+0.398+0.106<.001.00134
LSCCSNX10 →+0.646+0.162<.001<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0009156 vs GBP5 — LUAD

Per-sample scatter of Ribonucleoside monophosphate biosynthetic process activity vs GBP5 in LUAD.

Explore this scatter interactively →

Exploration